|
US3524846A
(en)
|
1967-06-02 |
1970-08-18 |
Syntex Corp |
Process for the didealkylation of phosphonate esters
|
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US4968788A
(en)
|
1986-04-04 |
1990-11-06 |
Board Of Regents, The University Of Texas System |
Biologically reversible phosphate and phosphonate protective gruops
|
|
US5091552A
(en)
|
1986-06-30 |
1992-02-25 |
Board Of Regents, The University Of Texas System |
Novel antitumor aldophosphamide analogs
|
|
JPH0738070B2
(ja)
|
1986-07-25 |
1995-04-26 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料
|
|
EP0284240B2
(en)
|
1987-03-09 |
1993-06-16 |
EASTMAN KODAK COMPANY (a New Jersey corporation) |
Photographic silver halide materials and process comprising a pyrazolotriazole coupler
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
ES2083580T3
(es)
|
1990-06-13 |
1996-04-16 |
Arnold Glazier |
Profarmacos de fosforo.
|
|
US5157027A
(en)
|
1991-05-13 |
1992-10-20 |
E. R. Squibb & Sons, Inc. |
Bisphosphonate squalene synthetase inhibitors and method
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
DE69426904T2
(de)
|
1993-06-29 |
2001-10-11 |
Mitsubishi Chemical Corp., Tokio/Tokyo |
Phosphonat-Nukleotid Ester-Derivate
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5780058A
(en)
|
1995-07-21 |
1998-07-14 |
Alza Corporation |
Oral delivery of discrete units
|
|
US6132420A
(en)
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
|
JPH09241284A
(ja)
|
1996-03-08 |
1997-09-16 |
Koji Yamashita |
新規なオキシアザホスホリン誘導体
|
|
MY125849A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
|
JPH1197740A
(ja)
|
1997-09-19 |
1999-04-09 |
Showa Denko Kk |
GaP発光ダイオード用エピタキシャルウェーハおよびGaP発光ダイオード
|
|
CA2315890C
(en)
|
1997-12-22 |
2009-08-11 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
|
EP1041968B1
(en)
|
1997-12-29 |
2004-03-03 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
|
AU1937099A
(en)
|
1997-12-31 |
1999-07-19 |
Alza Corporation |
Osmotic drug delivery monitoring system and method
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6365185B1
(en)
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
|
AU1238500A
(en)
|
1998-11-02 |
2000-05-22 |
Alza Corporation |
Controlled delivery of active agents
|
|
US6375975B1
(en)
|
1998-12-21 |
2002-04-23 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary application
|
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
US6503949B1
(en)
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
AU4537900A
(en)
|
1999-05-17 |
2000-12-05 |
Agouron Pharmaceuticals, Inc. |
Glucagon antagonists/inverse agonists
|
|
WO2000071511A2
(en)
|
1999-05-24 |
2000-11-30 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
EP1214324B1
(en)
|
1999-09-10 |
2006-06-14 |
Novo Nordisk A/S |
MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
|
|
DE10008329A1
(de)
|
2000-02-23 |
2001-08-30 |
Merck Patent Gmbh |
Aminosulfonylbiphenylderivate
|
|
KR20030029061A
(ko)
|
2000-06-23 |
2003-04-11 |
노보 노르디스크 에이/에스 |
글루카곤 길항제/역작용제
|
|
AU2002223501A1
(en)
|
2000-11-17 |
2002-05-27 |
Agouron Pharmaceuticals, Inc. |
Glucagon antagonists/inverse agonists
|
|
US7041646B2
(en)
|
2001-10-05 |
2006-05-09 |
Bayer Pharmaceuticals Corporation |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
|
|
AR036711A1
(es)
|
2001-10-05 |
2004-09-29 |
Bayer Corp |
Peptidos que actuan como agonistas del receptor del glp-1 y como antagonistas del receptor del glucagon y sus metodos de uso farmacologico
|
|
AU2002365622A1
(en)
|
2001-12-03 |
2003-06-17 |
Novo Nordisk A/S |
Novel glucagon antagonists
|
|
US6762318B2
(en)
|
2001-12-03 |
2004-07-13 |
Novo Nordisk A/S |
Glucagon antagonists
|
|
US6881746B2
(en)
|
2001-12-03 |
2005-04-19 |
Novo Nordick A/S |
Glucagon antagonists/inverse agonists
|
|
WO2003053938A1
(en)
|
2001-12-20 |
2003-07-03 |
Novo Nordisk A/S |
Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
|
|
US20030212119A1
(en)
|
2001-12-20 |
2003-11-13 |
Jesper Lau |
Novel glucagon receptor antagonists/inverse agonists
|
|
JP2006500325A
(ja)
|
2002-06-27 |
2006-01-05 |
ノボ ノルディスク アクティーゼルスカブ |
新規なグルカゴンアンタゴニスト
|
|
JP2006509015A
(ja)
|
2002-12-04 |
2006-03-16 |
メルク エンド カムパニー インコーポレーテッド |
スピロ環尿素、そのような化合物を含有する組成物、及び使用方法
|
|
MY141521A
(en)
|
2002-12-12 |
2010-05-14 |
Hoffmann La Roche |
5-substituted-six-membered heteroaromatic glucokinase activators
|
|
US20040152750A1
(en)
|
2002-12-20 |
2004-08-05 |
Kodra Janos Tibor |
Novel glucagon antagonists
|
|
US7572922B2
(en)
|
2003-01-27 |
2009-08-11 |
Merck & Co., Inc. |
Substituted pyrazoles, compositions containing such compounds and methods of use
|
|
US7138529B2
(en)
|
2003-04-16 |
2006-11-21 |
Hoffmann-La Roche Inc. |
Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
|
|
AU2004238240A1
(en)
|
2003-05-09 |
2004-11-25 |
Merck & Co., Inc. |
Benzimidazoles, compositions containing such compounds and methods of use
|
|
EP2428516A1
(en)
|
2003-11-19 |
2012-03-14 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
|
WO2005054213A1
(ja)
|
2003-12-02 |
2005-06-16 |
Shionogi & Co., Ltd. |
ペルオキシソーム増殖活性化受容体アゴニスト活性を有するイソキサゾール誘導体
|
|
US20070015757A1
(en)
|
2003-12-19 |
2007-01-18 |
Novo Nordisk A/S |
Novel Glucagon Antagonists/Inverse Agonists
|
|
US7301036B2
(en)
|
2003-12-19 |
2007-11-27 |
Merck & Co., Inc. |
Cyclic guanidines, compositions containing such compounds and methods of use
|
|
US7989457B2
(en)
|
2004-05-28 |
2011-08-02 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
|
SI1756064T1
(sl)
|
2004-06-04 |
2008-12-31 |
Merck & Co Inc |
Derivati pirazola, sestavki vsebujoäśi takĺ ne sestavine in postopki uporabe
|
|
PT1758853E
(pt)
|
2004-06-14 |
2010-03-02 |
Lilly Co Eli |
Antagonistas do receptor de glucagon, sua preparação e usos terapêuticos
|
|
EP1768954A4
(en)
|
2004-06-24 |
2008-05-28 |
Incyte Corp |
2-METHYLPROPANAMIDES AND THEIR USE AS PHARMACEUTICALS
|
|
DE602005017895D1
(de)
|
2004-07-07 |
2010-01-07 |
Merck & Co Inc |
Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
|
|
AU2005269792B9
(en)
|
2004-07-22 |
2008-11-27 |
Merck Sharp & Dohme Corp. |
Substituted pyrazoles, compositions containing such compounds and methods of use
|
|
US8084489B2
(en)
|
2005-02-11 |
2011-12-27 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
|
US8318760B2
(en)
|
2005-03-21 |
2012-11-27 |
Merck Sharp & Dohme Corp. |
Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use
|
|
CN101146763A
(zh)
|
2005-03-30 |
2008-03-19 |
默克公司 |
胰高血糖素受体拮抗剂化合物、含有这种化合物的组合物以及使用方法
|
|
JP2009502923A
(ja)
|
2005-07-26 |
2009-01-29 |
メルク エンド カムパニー インコーポレーテッド |
置換ピラゾールを合成するための方法
|
|
EP2096170B1
(en)
|
2005-09-19 |
2011-08-10 |
Isis Pharmaceuticals, Inc. |
Modulation of glucagon receptor expression
|
|
TW200745031A
(en)
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
|
CN101312940B
(zh)
|
2005-11-17 |
2012-11-14 |
伊莱利利公司 |
胰高血糖素受体拮抗剂、制备和治疗用途
|
|
ES2391109T3
(es)
|
2005-11-17 |
2012-11-21 |
Eli Lilly And Company |
Antagonistas del receptor de glucagón, preparación y usos terapéuticos
|
|
AU2006341392B2
(en)
|
2005-11-18 |
2012-05-17 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
|
CN101312723B
(zh)
|
2005-11-22 |
2012-01-11 |
伊莱利利公司 |
胰高血糖素受体拮抗剂、制备和治疗用途
|
|
EP1957484B1
(en)
|
2005-11-23 |
2010-03-03 |
Eli Lilly & Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
|
WO2007111864A2
(en)
|
2006-03-23 |
2007-10-04 |
Merck & Co., Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
|
CA2650619A1
(en)
|
2006-05-16 |
2007-11-29 |
Merck And Co., Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
|
JP5258563B2
(ja)
|
2006-06-29 |
2013-08-07 |
日産化学工業株式会社 |
αアミノ酸誘導体及びそれを有効成分として含む医薬
|
|
TW200821284A
(en)
|
2006-10-03 |
2008-05-16 |
Merck & Co Inc |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
|
US8519145B2
(en)
|
2006-12-02 |
2013-08-27 |
Seoul National University Industry Foundation |
Aryl compounds as PPAR ligands and their use
|
|
MX2009008534A
(es)
|
2007-02-09 |
2009-11-23 |
Metabasis Therapeutics Inc |
Antagonistas novedosos del receptor de glucagon.
|
|
EP2799428B1
(en)
|
2008-08-13 |
2016-11-16 |
Metabasis Therapeutics, Inc. |
Glucagon antagonists
|
|
JP2014523445A
(ja)
|
2011-07-18 |
2014-09-11 |
トーカイ ファーマシューティカルズ,インク. |
前立腺癌を処置するための新規な組成物及び方法
|
|
WO2015191900A1
(en)
*
|
2014-06-12 |
2015-12-17 |
Ligand Pharmaceuticals, Inc. |
Glucagon antagonists
|
|
CN106336387A
(zh)
*
|
2015-07-10 |
2017-01-18 |
浙江海正药业股份有限公司 |
酰胺类衍生物、其制备方法及其在医药上的用途
|
|
US20170143673A1
(en)
*
|
2015-11-24 |
2017-05-25 |
Remd Biotherapeutics, Inc. |
Methods For Treating Heart Failure Using Glucagon Receptor Antagonists
|
|
JP2021513564A
(ja)
|
2018-02-13 |
2021-05-27 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
グルカゴン受容体拮抗薬
|